- Home
- GTY vs CLDX Comparison
GTY vs CLDX Comparison
Compare GTY & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTY | CLDX |
|---|---|---|
| Founded | 1955 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1998 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GTY | CLDX |
|---|---|---|
| Price | $32.66 | $32.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $32.60 | ★ $46.60 |
| AVG Volume (30 Days) | 342.4K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 5.85% | N/A |
| EPS Growth | ★ 8.00 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $221,727,000.00 | $12,743,000.00 |
| Revenue This Year | $9.39 | $111.39 |
| Revenue Next Year | $7.83 | $235.85 |
| P/E Ratio | $77.17 | ★ N/A |
| Revenue Growth | 9.02 | ★ 87.78 |
| 52 Week Low | $25.39 | $17.87 |
| 52 Week High | $34.75 | $35.83 |
Technical Indicators
Market Signals| Indicator | GTY | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 47.65 |
| Support Level | $31.56 | $28.30 |
| Resistance Level | $34.08 | $34.52 |
| Average True Range (ATR) | 0.69 | 1.20 |
| MACD | -0.14 | -0.28 |
| Stochastic Oscillator | 8.88 | 8.85 |
Price Performance
Historical ComparisonAbout GTY Getty Realty Corporation
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.